Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX )
NCT ID: NCT04095078
Last Updated: 2022-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2020-03-10
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Airway Clearance in CF Patients
NCT04096664
Effects of SIMEOX on Airway Clearance in Cystic Fibrosis
NCT04187924
Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis
NCT04084041
MUCOviscidose EXacerbation Outils Connectés Education Thérapeutique
NCT03304028
Use of a Connected Companion in Children With Cystic Fibrosis
NCT04705636
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SIMEOX
Use the device for 3 months in addition to usual care
SIMEOX
Use without obligation, in autonomous and at home of the bronchial clearance device: SIMEOX
Control
Usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SIMEOX
Use without obligation, in autonomous and at home of the bronchial clearance device: SIMEOX
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* same criteria as HOME-CARE SIMEOX study
Exclusion Criteria
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icadom
INDUSTRY
Physio-Assist
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boubou Camara, MD
Role: PRINCIPAL_INVESTIGATOR
CHUGA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grenoble University Hospital : pneumo-pediatric department
Grenoble, , France
Grenoble University-Affiliated Hospital : Pneumology department
Grenoble, , France
Montpellier Hospital Center
Montpellier, , France
Nice University-Affiliated Hospital : Pneumology department
Nice, , France
Nice University-Affiliated Hospital : Pneumo-pediatric department
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ancillary Home-Care SIMEOX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.